Published in Proteome Sci on March 19, 2009
Celiac disease. N Engl J Med (2007) 10.98
The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol (1999) 6.27
Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol (2007) 3.23
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology (1998) 2.69
An overview on biological mechanisms of PPARs. Pharmacol Res (2005) 2.43
Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res (2008) 1.83
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology (1997) 1.80
Coeliac disease: an update for pathologists. J Clin Pathol (2006) 1.76
Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut (1991) 1.61
On the role of galectin-3 in cancer apoptosis. Apoptosis (2005) 1.60
Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics (2002) 1.52
Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol (2002) 1.44
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res (2008) 1.38
Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood (2007) 1.38
Proteome and glycosylation mapping identifies post-translational modifications associated with aggressive breast cancer. Proteomics (2001) 1.18
An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut (2002) 1.08
Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis (2000) 1.04
Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut (2002) 0.98
NF-kappa B p65 transactivation domain is involved in the NF-kappa B-inducing kinase pathway. Biochem Biophys Res Commun (2003) 0.98
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig Liver Dis (2007) 0.93
Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer. Mol Cancer Res (2006) 0.92
Searchable high-resolution 2D gel proteome of the human colon crypt. J Proteome Res (2007) 0.92
The new functions of the gut in the control of glucose homeostasis. Curr Opin Clin Nutr Metab Care (2005) 0.89
Two-dimensional gel proteome reference map of blood monocytes. Proteome Sci (2006) 0.88
HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa. Proteomics Clin Appl (2008) 0.80
Proteomic analysis of colonic crypts from normal, multiple intestinal neoplasia and p53-null mice: a comparison with colonic polyps. Electrophoresis (2000) 0.79
Comment re: Ran-GTP control of tumor cell mitosis. Cancer Res (2009) 0.79
Proteomic analysis of the small intestine and colon epithelia of adenomatous polyposis coli gene-mutant mice by two-dimensional gel electrophoresis. Electrophoresis (2000) 0.79
Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells. Clin Exp Immunol (2007) 0.78
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell (2005) 2.65
[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging (2006) 2.63
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum (2013) 2.52
Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. J Clin Oncol (2009) 2.40
Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc (2008) 1.69
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell (2008) 1.62
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood (2002) 1.58
Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie (2009) 1.58
HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. Hepatology (2005) 1.57
Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients. Clin Cancer Res (2005) 1.47
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A (2013) 1.44
Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma. Blood (2008) 1.43
The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol (2009) 1.43
Feasibility and diagnostic agreement in teledermatopathology using a virtual slide system. Hum Pathol (2007) 1.39
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood (2010) 1.37
Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res (2008) 1.34
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood (2010) 1.27
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res (2009) 1.22
Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy. Int J Cancer (2006) 1.21
Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. J Virol (2006) 1.18
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther (2008) 1.16
Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus. Gastroenterology (2012) 1.12
Consensus guidelines on severe acute pancreatitis. Dig Liver Dis (2015) 1.12
Breast metastasis of primary colon cancer with micrometastasis in the axillary sentinel node: a metastasis that metastasized? Diagn Pathol (2011) 1.09
Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol (2011) 1.08
Clinical and dermoscopic features of porokeratosis of Mibelli. Arch Dermatol (2009) 1.08
Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo. Cell Cycle (2014) 1.07
Risk factors for ovarian cancer histotypes. Eur J Cancer (2007) 1.06
Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum (2003) 1.05
C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. Eur J Cancer (2009) 1.04
Identification of novel chimpanzee MHC class I and II alleles using an improved sequence-based typing strategy. Hum Immunol (2006) 1.04
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol (2004) 1.02
Renal cell cancer and body size at different ages: an Italian multicenter case-control study. Am J Epidemiol (2007) 1.01
Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer. Int J Cancer (2008) 1.00
Interobserver agreement in describing video capsule endoscopy findings: a multicentre prospective study. Dig Liver Dis (2011) 0.99
Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol (2009) 0.97
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. EMBO Mol Med (2013) 0.97
Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease. Clin Nucl Med (2006) 0.95
'Genetic profiling' and ovarian cancer therapy (review). Mol Med Rep (2011) 0.95
Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. Leuk Lymphoma (2008) 0.95
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma (2002) 0.93
An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research stakeholders in a cancer biobank. BMC Med Ethics (2013) 0.93
Differential proteomic analysis of hepatocellular carcinoma. Int J Oncol (2010) 0.92
Expression profiles in malignant fibrous histiocytomas: clues for differentiating 'spindle cell' and 'pleomorphic' subtypes. Eur J Cancer (2007) 0.91
Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol (2007) 0.91
Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature. Hum Pathol (2009) 0.91
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections. PLoS One (2011) 0.91
Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens. J Pharmacol Exp Ther (2013) 0.91
Negative pigment network and shiny white streaks: a dermoscopic-pathological correlation study. Am J Dermatopathol (2014) 0.91
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas. Br J Haematol (2009) 0.90
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy. PLoS One (2011) 0.90
EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential. PLoS One (2012) 0.90
A liquid chromatography-tandem mass spectrometry method for the simultaneous determination of exemestane and its metabolite 17-dihydroexemestane in human plasma. J Mass Spectrom (2009) 0.89
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinology (2008) 0.89
Fast liquid chromatography-tandem mass spectrometry method for routine assessment of irinotecan metabolic phenotype. Ther Drug Monit (2010) 0.89
Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment. Pharmacogenet Genomics (2013) 0.88
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J Am Acad Dermatol (2011) 0.88
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas. J Hepatol (2008) 0.88
Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J Pathol (2005) 0.88
Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities. Clin Nucl Med (2012) 0.88
Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy. Int J Cancer (2008) 0.87
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Cancer Res (2005) 0.87
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes. Int J Cancer (2009) 0.86
Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). Mol Med Rep (2010) 0.86
Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomics. Proteomics Clin Appl (2010) 0.86
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. Haematologica (2004) 0.86
Incidental Epstein-Barr virus associated atypical lymphoid proliferation arising in a left atrial myxoma: a case of long survival without any postsurgical treatment and review of the literature. Cardiovasc Pathol (2012) 0.85
Pitfalls in the dermoscopic diagnosis of amelanotic melanoma. J Am Acad Dermatol (2010) 0.85
Gastrointestinal stromal tumors: report of an audit and review of the literature. Eur J Cancer Prev (2009) 0.85
Stathmin is dispensable for tumor onset in mice. PLoS One (2012) 0.84
Androgen receptor serine 81 mediates Pin1 interaction and activity. Cell Cycle (2012) 0.84
A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med (2012) 0.84
Critical choices for modeling breast cancer in transgenic mouse models. J Cell Physiol (2012) 0.84
BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival. Head Neck (2010) 0.84
Hepatitis C virus (HCV) I hepatitis C virus (HCV) infection and lymphoproliferative disorders. Front Biosci (2005) 0.84
Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets. J Cell Physiol (2012) 0.84
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas. Clin Cancer Res (2012) 0.83
Lack of HCV infection in malignant cells refutes the hypothesis of a direct transforming action of the virus in the pathogenesis of HCV-associated B-cell NHLs. Tumori (2002) 0.83
Interferon-based therapy for chronic hepatitis C: current and future perspectives. Hepat Mon (2010) 0.83
Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue. Leukemia (2003) 0.83
Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model. J Med Chem (2015) 0.83
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease. Scand J Gastroenterol (2007) 0.83
KIR/HLA combination associated with the risk of complications in celiac disease. Int J Biol Markers (2011) 0.83
The versatile role of gliadin peptides in celiac disease. Clin Biochem (2012) 0.83